Research never stops

Top Story

Evotec achieves first milestone in neurodegeneration alliance with Celgene

Hamburg, Germany, 10 October 2017: Evotec AG announced today that its strategic alliance with Celgene has reached a first milestone triggering revenues of $ 5.0 m to Evotec, which are recognised in the third quarter of 2017.

- read more

Evotec invests in Exscientia to advance AI-driven drug discovery

Hamburg, Germany, Dundee, UK, 28 September 2017: Evotec AG and Exscientia Ltd today announced that Evotec has made a EUR 15 m investment to take a minority stake in Exscientia.

- read more

Evotec and MaRS Innovation establish Academic Bridge "LAB150" in Toronto

Hamburg, Germany, 14 September 2017: Evotec AG and MaRS Innovation today announced the launch of "LAB150".

- read more
loading weather report
Loading weather report...


Nov 08, 2017 - Financial Calendar 2017

Company Presentation October

Building integrated and high-value drug discovery alliances
2017-10_Evotec_Company presentation_October